All In Biotech

Drug Trial Radar · NCT02481440

Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI

Repeated Subarachnoid Administrations of Human Umbilical Cord Mesenchymal Stem Cells in Treating Spinal Cord Injury

Last checked: Nov 19, 2026Latest source record: Jun 30, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

102

Actual

Start

Mar 30, 2018

Primary completion

Mar 31, 2020

Study completion Mar 31, 2020

Sponsor

Lead sponsor
Limin RongAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 25, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of repeated intrathecal administrations of allogeneic human umbilical cord mesenchymal stem cells for the treatment of spinal cord injury.

Conditions

  • Spinal Cord Injuries

Interventions

  • human umbilical cord mesenchymal stem cells (hUC-MSCs)Biological

    Four times of intrathecal administrations of hUC-MSCs

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. American Spinal Injury Association (ASIA) Total Score at the Fourth Follow-upTime frame: at 12 months following the final administration of hUC-MSCs
  2. SCI Functional Rating Scale of the International Association of Neurorestoratology (IANR-SCIFRS) Total Score at the Fourth Follow-upTime frame: at 12 months following the final administration of hUC-MSCs

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Third Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.